Title:
TACI-免疫グロブリン融合タンパク質
Document Type and Number:
Japanese Patent JP2004535182
Kind Code:
A
Abstract:
Molecules that interfere with the binding of a tumor necrosis factor receptor with its ligand, such as a soluble receptor, have proven usefulness in both basic research and as therapeutics. The present invention provides improved soluble transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptors.
Inventors:
Rixon, Mark W
Gross, Jane A.
Gross, Jane A.
Application Number:
JP2002592326A
Publication Date:
November 25, 2004
Filing Date:
May 20, 2002
Export Citation:
Assignee:
Zymogenetics, Incorporated
International Classes:
C12N15/09; A61K38/00; A61K39/395; A61K48/00; A61P35/00; C07K14/705; C07K14/715; C07K16/00; C07K19/00; (IPC1-7): C12N15/09; A61K38/00; A61K39/395; A61K48/00; A61P35/00; C07K14/715; C07K16/00; C07K19/00
Attorney, Agent or Firm:
Atsushi Aoki
Takashi Ishida
Fukumoto product
Tetsuji Koga
Masaya Nishiyama
Takashi Ishida
Fukumoto product
Tetsuji Koga
Masaya Nishiyama